PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

Autor: Schmidt, A.F., Swerdlow, D.I., Holmes, M.V., Patel, R.S., Fairhurst-Hunter, Z., Lyall, D.M., Hartwig, F.P., Horta, B.L., Hypponen, E., Power, C., Moldovan, M., Iperen, E. van, Hovingh, G.K., Demuth, I., Norman, K., Steinhagen-Thiessen, E., Demuth, J., Bertram, L., Liu, T., Coassin, S., Willeit, J., Kiechl, S., Willeit, K., Mason, D., Wright, J., Morris, R., Wanamethee, G., Whincup, P., Ben-Shlomo, Y., McLachlan, S., Price, J.F., Kivimaki, M., Welch, C., Sanchez-Galvez, A., Marques-Vidal, P., Nicolaides, A., Panayiotou, A.G., Onland-Moret, N.C., Schouw, Y.T. van der, Matullo, G., Fiorito, G., Guarrera, S., Sacerdote, C., Wareham, N.J., Langenberg, C., Scott, R., Luan, J.A., Bobak, M., Malyutina, S.A., Pajak, A., Kubinova, R., Tamosiunas, A., Pikhart, H., Husemoen, L.L.N., Grarup, N., Pedersen, O., Hansen, T., Linneberg, A., Simonsen, K.S., Cooper, J., Humphries, S.E., Brilliant, M., Kitchner, T., Hakonarson, H., Carrell, D.S., McCarty, C.A., Kirchner, H.L., Larson, E.B., Crosslin, D.R., Andrade, M. de, Roden, D.M., Denny, J.C., Carty, C., Hancock, S., Attia, J., Holliday, E., Donnell, M.O., Yusuf, S., Chong, M., Pare, G., Harst, P. van der, Said, M.A., Eppinga, R.N., Verweij, N., Snieder, H., Christen, T., Mook-Kanamori, D.O., Gustafsson, S., Lind, L., Ingelsson, E., Pazoki, R., Franco, O., Hofman, A., Uitterlinden, A., Dehghan, A., Teumer, A., Baumeister, S., Dorr, M., Lerch, M.M., Volker, U., Volzke, H., Ward, J., Pell, J.P., Smith, D.J., Meade, T., Maitland-van der Zee, A.H., Baranova, E.V., Young, R., Ford, I., Campbell, A., Padmanabhan, S., Bots, M.L., Grobbee, D.E., Froguel, P., Thuillier, D., Balkau, B., Bonnefond, A., Cariou, B., Smart, M., Bao, Y., Kumari, M., Mahajan, A., Ridker, P.M., Chasman, D.I., Reiner, A.P., Lange, L.A., Ritchie, M.D., Asselbergs, F.W., Casas, J.P., Keating, B.J., Preiss, D., Hingorani, A.D., Sattar, N., LifeLines Cohort Study Grp, UCLEB Consortium

Publikováno v: The Lancet Diabetes and Endocrinology
Lancet Diabetes and Endocrinology
Lancet Diabetes and Endocrinology, Elsevier, 2017, Equipe IV, 5 (2), pp.97--105. ⟨10.1016/S2213-8587(16)30396-5⟩

BACKGROUND:Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions in both the concentration of LDL cholesterol and the risk of coronary heart disease, but also with modest hyperglycaemia, increased bodywei

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ffe8ffe3346ebcb4fb3a5b1c29c26a92
http://hdl.handle.net/1887/111905

1502P - Insomnia prevalence in an oncology patient population: an Irish tertiary referral centre experience

Autor: Harrold, E.C., Idris, A.F., Keegan, N.M., Corrigan, L., Teo, M.Y., Lim, S.T., Duff, E., Donnell, M.O., Kennedy, J., O'Donnell, D., Sukor, S., Grant, C., Gallagher, D., Collier, S., Kingston, T., O'Dwyer, A.M., Cuffe, S.

Publikováno v: In Annals of Oncology 1 October 2016 27 Supplement 6:vi520-vi520

LV STRAIN ESTIMATION FROM 4D ECHOCARDIOGRAPHY.

Autor: Duncan, J., Ping Yan, Yun Zhu, Sinusas, A., Congxian Jia, Donnell, M.O.

Publikováno v: 2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro; 2007, p696-699, 4p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.